FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000520014> ?p ?o ?g. }

• W2000520014 endingPage "237" @default.
• W2000520014 startingPage "236" @default.
• W2000520014 abstract "Back to table of contents Previous article Next article LetterFull AccessAcute Psychosis Associated With ButorphanolAmanda Davis, Beth Yudofsky, M.D., and Saleem Quidwai, M.D., Amanda DavisSearch for more papers by this author, Beth YudofskySearch for more papers by this author, M.D., and Saleem QuidwaiSearch for more papers by this author, M.D., Consultation and Liaison Psychiatry Service, Ben Taub General Hospital, Houston, TXPublished Online:1 May 1998https://doi.org/10.1176/jnp.10.2.236AboutSectionsView EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail SIR: Although the association between opioids and psychotic symptoms has been reported in the past, we could not find a report of acute psychosis associated with butorphanol (Stadol) in the literature.Case ReportA 22-year-old primigravid female who had been pregnant 37 weeks and 6 days was admitted in labor. Early in labor the patient was given 1 mg of butorphanol intravenously and reported that minutes later she became sweaty and began to “see visions” of flowers falling on her. Four hours later, the patient had a traumatic delivery, requiring forceps and sustaining a fourth-degree perineal laceration. After delivery, the patient began to perceive herself as a character in a horror movie every time she closed her eyes. She also strongly believed that someone was going to hurt her baby and kept the baby close to her at all times. She denied auditory hallucinations or any past psychotic symptoms, and she denied current symptoms of depression, mania, and anxiety. The patient did not want to hurt herself or the baby and denied obsessions and compulsions. She had no past medical or surgical history, no past or present use of tobacco, alcohol, or illicit drugs, and no medications prior to her hospitalization. She was breast feeding her child. Her inpatient medications other than the butorphanol injection included a multivitamin, iron supplements, milk of magnesia, docusate sodium, and oxytocin during labor. Her family history was negative for psychiatric disorders. Social history was significant for a “violation” at the age of 7 by an undisclosed family member. She was a married, immigrant housekeeper, and her family remained in her country of origin.On initial mental status examination, the patient was sitting up in bed with her baby next to her. Mood was dysthymic and irritable, with a labile affect, and her thought content included visual hallucinations and paranoid delusions. Physical examination was normal except for trauma to the perineum. Her laboratory results were significant only for a mild anemia, negative HIV test, and nonreactive rapid plasma reagent test. Other serum and urine analyses were normal. On mental status examination 40 hours after the butorphanol injection, mood was good and affect was appropriate, with no visual hallucinations or delusions. On follow-up 2 weeks later, the psychosis still was resolved, with no report of recurrence.DiscussionButorphanol, as well as nalbuphine, is an agonist of the kappa opioid receptor and partial agonist of the mu receptor. Butorphanol has the additional properly of being a partial agonist of the sigma receptors, which is thought to be responsible for its psychomimetic effects (usually manifested as dysphoric and hallucinatory symptoms). Metabolism of the drug is hepatic, with renal excretion and a half-life of 3 to 4 hours. Usual side effects of butorphanol are feelings of sedation or floating, difficulty concentrating, sweating, and skin itching.1 Other analgesics such as morphine and nalorphine have been reported to cause dysphoria or visual hallucinations in the past.2The acute onset and rapid resolution of psychotic symptoms in this case is typical for drug-induced psychosis. The patient's somatic reaction to the injection (sweating and analgesia) was coincident with the onset of the visual hallucinations. That was important to note in this case, since postpartum psychosis or depression was included in the initial differential. The paranoid delusion, as well as the hallucinations, disappeared in approximately 10 half-lives of the drug. Butorphanol is used commonly in labor and delivery situations, both because of its superior analgesia in females (thought to be secondary to differences in kappa-opioid–activated endogenous pain-modulating circuits3) and because of its safety profile. Clinicians should be aware of this possible reaction in susceptible patients and provide reassurance and supportive care.References1. Zacny JP, Lichtor JL, Thapar P, et al: Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther l994; 270:579–588Google Scholar2. Lasagna L, Beecher HK: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J Pharmacol Exp Ther 1954; 112:356–363Medline, Google Scholar3. Gear RW, Miaskowski C, Gordon NC, et al: Kappa-opioids produce significantly greater analgesia in women than in men. Nature Medicine 1996; 2:1184–1185Crossref, Medline, Google Scholar FiguresReferencesCited byDetailsCited ByArchives of Women's Mental Health, Vol. 20, No. 1Psychiatric side effects of medications prescribed in internal medicine1 April 2022 | Dialogues in Clinical Neuroscience, Vol. 5, No. 2Reactions Weekly, Vol. &NA;, No. 707 Volume 10Issue 2 May 1998Pages 236-237 Metrics History Published online 1 May 1998 Published in print 1 May 1998" @default.
• W2000520014 created "2016-06-24" @default.
• W2000520014 creator A5021946134 @default.
• W2000520014 creator A5027830190 @default.
• W2000520014 creator A5055903850 @default.
• W2000520014 date "1998-05-01" @default.
• W2000520014 modified "2023-09-27" @default.
• W2000520014 title "Acute Psychosis Associated With Butorphanol" @default.
• W2000520014 doi "https://doi.org/10.1176/jnp.10.2.236" @default.
• W2000520014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9608418" @default.
• W2000520014 hasPublicationYear "1998" @default.
• W2000520014 type Work @default.
• W2000520014 sameAs 2000520014 @default.
• W2000520014 citedByCount "5" @default.
• W2000520014 countsByYear W20005200142016 @default.
• W2000520014 countsByYear W20005200142017 @default.
• W2000520014 crossrefType "journal-article" @default.
• W2000520014 hasAuthorship W2000520014A5021946134 @default.
• W2000520014 hasAuthorship W2000520014A5027830190 @default.
• W2000520014 hasAuthorship W2000520014A5055903850 @default.
• W2000520014 hasConcept C118552586 @default.
• W2000520014 hasConcept C139719470 @default.
• W2000520014 hasConcept C154945302 @default.
• W2000520014 hasConcept C15744967 @default.
• W2000520014 hasConcept C162324750 @default.
• W2000520014 hasConcept C187212893 @default.
• W2000520014 hasConcept C2776174506 @default.
• W2000520014 hasConcept C2776809841 @default.
• W2000520014 hasConcept C2776867660 @default.
• W2000520014 hasConcept C2779727114 @default.
• W2000520014 hasConcept C2779990769 @default.
• W2000520014 hasConcept C2780733359 @default.
• W2000520014 hasConcept C2781020239 @default.
• W2000520014 hasConcept C2911011789 @default.
• W2000520014 hasConcept C41008148 @default.
• W2000520014 hasConcept C42219234 @default.
• W2000520014 hasConcept C558461103 @default.
• W2000520014 hasConcept C71924100 @default.
• W2000520014 hasConceptScore W2000520014C118552586 @default.
• W2000520014 hasConceptScore W2000520014C139719470 @default.
• W2000520014 hasConceptScore W2000520014C154945302 @default.
• W2000520014 hasConceptScore W2000520014C15744967 @default.
• W2000520014 hasConceptScore W2000520014C162324750 @default.
• W2000520014 hasConceptScore W2000520014C187212893 @default.
• W2000520014 hasConceptScore W2000520014C2776174506 @default.
• W2000520014 hasConceptScore W2000520014C2776809841 @default.
• W2000520014 hasConceptScore W2000520014C2776867660 @default.
• W2000520014 hasConceptScore W2000520014C2779727114 @default.
• W2000520014 hasConceptScore W2000520014C2779990769 @default.
• W2000520014 hasConceptScore W2000520014C2780733359 @default.
• W2000520014 hasConceptScore W2000520014C2781020239 @default.
• W2000520014 hasConceptScore W2000520014C2911011789 @default.
• W2000520014 hasConceptScore W2000520014C41008148 @default.
• W2000520014 hasConceptScore W2000520014C42219234 @default.
• W2000520014 hasConceptScore W2000520014C558461103 @default.
• W2000520014 hasConceptScore W2000520014C71924100 @default.
• W2000520014 hasIssue "2" @default.
• W2000520014 hasLocation W20005200141 @default.
• W2000520014 hasLocation W20005200142 @default.
• W2000520014 hasOpenAccess W2000520014 @default.
• W2000520014 hasPrimaryLocation W20005200141 @default.
• W2000520014 hasRelatedWork W1596694132 @default.
• W2000520014 hasRelatedWork W2071484728 @default.
• W2000520014 hasRelatedWork W2120822674 @default.
• W2000520014 hasRelatedWork W2391925305 @default.
• W2000520014 hasRelatedWork W2478271882 @default.
• W2000520014 hasRelatedWork W2517868470 @default.
• W2000520014 hasRelatedWork W2982491507 @default.
• W2000520014 hasRelatedWork W3137166182 @default.
• W2000520014 hasRelatedWork W4226482530 @default.
• W2000520014 hasRelatedWork W79847179 @default.
• W2000520014 hasVolume "10" @default.
• W2000520014 isParatext "false" @default.
• W2000520014 isRetracted "false" @default.
• W2000520014 magId "2000520014" @default.
• W2000520014 workType "article" @default.